Part D Enrollment Doesn't Improve Outcomes After AMI

This article originally appeared here.
Share this content:
Part D Enrollment Doesn't Improve Outcomes After AMI
Part D Enrollment Doesn't Improve Outcomes After AMI

THURSDAY, Oct. 29, 2015 (HealthDay News) -- For patients with acute myocardial infarction (AMI), enrollment in Part D by hospital discharge is not associated with improved outcomes, according to a study published online Oct. 27 in Circulation: Cardiovascular Quality and Outcomes.

Abhinav Goyal, M.D., from the Emory University School of Medicine in Atlanta, and colleagues describe trends in Medicare Part D enrollment in 59,149 Medicare beneficiaries discharged after AMI. After adjustment for patient and hospital factors, the authors compared 30-day and one-year outcomes (all-cause death, all-cause readmissions, and major adverse cardiac events) among Part D enrollees (49.5 percent) and non-enrollees.

The researchers found that enrollees more often had all-cause 30-day death (4.0 versus 3.3 percent), but after multivariable adjustment this association was not statistically significant (adjusted hazard ratio, 1.06; 95 percent confidence interval, 0.97 to 1.17). The unadjusted risks for 30-day all-cause readmission or major cardiac events, and for one-year mortality, all-cause readmission, or major adverse cardiac events, were also increased for enrollees, but after multivariable adjustment these correlations were attenuated. Among Part D enrollees, secondary prevention medication adherence remained low at one year post-discharge.

"Only half of Medicare-insured patients with AMI were enrolled in Part D by hospital discharge, and their 30-day and one-year adjusted outcomes did not differ substantially from non-enrollees," the authors write. "There remain opportunities for improvement in medication adherence among patients with prescription drug coverage."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Generic EpiPen

FDA Approves First Generic EpiPen

Approval will address both rising costs and shortages of epinephrine

Report Details Corneal Infection Tied to Sleeping in Contacts

Report Details Corneal Infection Tied to Sleeping in ...

Six patients reported sleeping in lenses on regular basis; most had vision loss, permanent damage

Honey May Protect Children Who Swallow Button Batteries

Honey May Protect Children Who Swallow Button Batteries

Honey and Carafate appear to rapidly protect against batteries' caustic effects

is free, fast, and customized just for you!




Already a member?

Sign In Now »